Note on labeling: the events below come from r/peptides, r/melanotan, and community sources for research-peptide melanotan-1 used for cosmetic tanning
there is no safety data, so risk is simply unknown
Study-related adverse events The adverse events most commonly reported in 5% of adult patients treated with Victoza 1.8 mg vs Januvia 100 mg, both in combination with metformin, were nausea (21.8% vs 7.8%), diarrhea (16.3% vs 9.3%), decreased appetite (8.9% vs 3.4%), vomiting (7.4% vs 4.9%), headache (6.4% vs 5.9%), nasopharyngitis (5.9% vs 3.4%), and increased lipase (5.5% vs 4.4%)
The right context depends on the patients goals and medical review
Never share pens or needles with others, even family members
This large range reflects the paucity of good data